AMRS - AMYRIS TO PARTICIPATE AT SEPTEMBER INVESTOR CONFERENCES

PR Newswire

EMERYVILLE, Calif. , Sept. 7, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform and clean beauty consumer brands, today announced that management will participate in fireside chats moderated by equity research analysts, and provide updates, at two upcoming investor conferences:

• H.C. Wainwright 24th Annual Global Investment Conference, Monday, September 12 at 7:00 AM ET (virtual)
• Piper Sandler Growth Frontiers Conference, Tuesday, September 13 at 3:30 PM CT / 4:30 PM ET (in-person at Nashville, TN )

Live webcasts of the presentations and replays will be available on the Investor Relations section of the company's website at https://investors.amyris.com/events-and-presentations .

Amyris (Nasdaq: AMRS) is a leading synthetic biotechnology company, transitioning the Clean Health & Beauty and Flavors & Fragrances markets to sustainable ingredients through fermentation and the company's proprietary Lab-to-Market™ technology platform. This Amyris platform leverages state-of-the-art machine learning, robotics and artificial intelligence, enabling the company to rapidly bring new innovation to market at commercial scale. Amyris ingredients are included in over 20,000 products from the world's top brands, reaching more than 300 million consumers. Amyris also owns and operates a family of consumer brands that is constantly evolving to meet the growing demand for sustainable, effective and accessible products. For more information, please visit http://www.amyris.com .

Amyris, the Amyris logo, and Lab-to-Market, are trademarks or registered trademarks of Amyris, Inc. or its subsidiaries in the U.S. and/or other countries.

SOURCE Amyris, Inc.